ADRIANA GONZALEZ: Open Payments
NPI 1588191308 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 28 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $741 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $272 |
| Otsuka America Pharmaceutical, Inc. | 6 | $193 |
| Boston Scientific Corporation | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Abbott Laboratories | 2 | $52 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| ACADIA Pharmaceuticals Inc | 2 | $38 |
| ABBVIE INC. | 1 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Auvelity, REXULTI, GreenLight XPS, PLUVICTO, ESPRIT, INGREZZA, NUPLAZID, LINZESS.
Industry payments across FL — which companies pay providers there.
